New Zealand markets closed

Terumo Corporation (TRUMF)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
17.530.00 (0.00%)
As of 12:00PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close17.53
Open17.53
Bid15.72 x 28000
Ask16.71 x 0
Day's range17.53 - 17.53
52-week range12.48 - 19.84
Volume132
Avg. volume2,001
Market cap26.028B
Beta (5Y monthly)0.47
PE ratio (TTM)38.96
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield0.17 (1.00%)
Ex-dividend date27 Sept 2024
1y target estN/A
  • PR Newswire

    Terumo Cardiovascular Announces 510(K) Clearance for the CDI OneView™ Monitoring System

    Terumo Cardiovascular, a global leader in cardiovascular surgery technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the CDI OneView Monitoring System. The next-generation CDI Systems platform provides visibility of key patient parameters during cardiopulmonary bypass surgery, critical to perfusion safety and improving patient outcomes.

  • PR Newswire

    FDA Clears the Individualized Nomogram for Rika Plasma Donation System

    Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company, recently received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Rika Plasma Donation System™ with the iNomi™ Nomogram. This innovation means that plasma collection volume can be determined by an individual donor's height, weight and hematocrit level on the day they donate plasma.

  • PR Newswire

    Terumo Medical Corporation's New AZUR HydroPack™ Peripheral Coil System Provides a Soft-Packing, Long-Lasting Solution to Embolotherapy

    Terumo Medical Corporation is pleased to announce the launch of its new AZUR HydroPack Peripheral Coil System in the United States. The AZUR HydroPack Coil System is a soft, universal-shaped platinum and hydrogel coil designed to find and fill empty space within the vessel. It is also the only packing coil to use proprietary designed hydrogel technology to create a gel core for mechanical occlusion, a unique feature of AZUR peripheral coils.[1] Terumo received Food and Drug Administration cleara